We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$20.1B
AUM Growth
+$3.5B
Cap. Flow
+$2.5B
Cap. Flow %
12.41%
Top 10 Hldgs %
33.13%
Holding
257
New
120
Increased
40
Reduced
39
Closed
20

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$546M
2
WTW icon
Willis Towers Watson
WTW
+$471M
3
MA icon
Mastercard
MA
+$344M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$240M
5
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$238M

Top Sells

Rank Stock Value
1
TIF
Tiffany & Co.
TIF
+$301M
2
NYT icon
New York Times
NYT
+$209M
3
V icon
Visa
V
+$194M
4
ELV icon
Elevance Health
ELV
+$145M
5
ABBV icon
AbbVie
ABBV
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 34.84%
2 Financials 13.62%
3 Communication Services 11.15%
4 Technology 9.41%
5 Industrials 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMA
76
ImageneBio Inc
IMA
$64.6M
$38.1M 0.19%
+112,459
New +$38.5M
RP
77
DELISTED
RealPage, Inc.
RP
$36.2M 0.18%
+415,000
New +$36.1M
QTRX icon
78
Quanterix
QTRX
$190M
$35.1M 0.17%
+600,000
New +$40.6M
CHNG
79
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$32.1M 0.16%
+1,453,600
New +$33.6M
NVAX icon
80
Novavax
NVAX
$1.31B
$31.7M 0.16%
175,000
-100,000
-36% -$19.9M
COHR
81
DELISTED
Coherent Inc
COHR
$31.6M 0.16%
+125,000
New +$27.8M
PLRX icon
82
Pliant Therapeutics
PLRX
$65M
$30.1M 0.15%
764,262
– –
BIIB icon
83
Biogen
BIIB
$30.7B
$28.8M 0.14%
103,000
– –
IONS icon
84
Ionis Pharmaceuticals
IONS
$9.4B
$28.3M 0.14%
630,500
-119,500
-16% -$6.66M
KVSC
85
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$28.1M 0.14%
+2,809,000
New +$27.8M
VAR
86
DELISTED
Varian Medical Systems, Inc.
VAR
$26.5M 0.13%
+150,000
New +$26.4M
NUVB icon
87
Nuvation Bio
NUVB
$2.32B
$26.1M 0.13%
2,500,000
– –
SAGE
88
DELISTED
Sage Therapeutics
SAGE
$25.8M 0.13%
345,000
-705,000
-67% -$57.8M
TGTX icon
89
TG Therapeutics
TGTX
$7.62B
$24.1M 0.12%
500,000
+400,000
+400% +$19.2M
CLVR
90
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$23.4M 0.12%
75,936
-6,667
-8% -$2.43M
CNST
91
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$23.4M 0.12%
1,000,000
+250,000
+33% +$7.57M
ORTX
92
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$23.3M 0.12%
+321,543
New +$22.8M
NXDR
93
Nextdoor Holdings
NXDR
$986M
$22.7M 0.11%
+2,250,000
New +$22.5M
SRPT icon
94
Sarepta Therapeutics
SRPT
$1.77B
$22.4M 0.11%
300,000
-300,000
-50% -$27.7M
REVHU
95
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
$20.1M 0.1%
+2,000,000
New +$20.1M
DCRCU
96
DELISTED
Decarbonization Plus Acquisition Corporation III Unit
DCRCU
$19.9M 0.1%
+2,000,000
New +$19.9M
ZYME icon
97
Zymeworks
ZYME
$1.67B
$18.9M 0.09%
600,000
-150,000
-20% -$6.1M
FPRX
98
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$18.9M 0.09%
501,618
+101,618
+25% +$2.53M
FVIV.U
99
DELISTED
Fortress Value Acquisition Corp. IV Units, each consisting of one share of Class A common stock and one-eighth of one redeemable Warrant
FVIV.U
$17.3M 0.09%
+1,750,000
New +$17.5M
RC
100
Ready Capital
RC
$308M
$16.8M 0.08%
1,250,226
-100,000
-7% -$1.3M
2 3
4
5 6

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Farallon Capital Management held 257 positions worth $20.1B, up 21% from $16.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Farallon Capital Management deployed $2.5B of net new capital in Q1 2021, opening 120 new positions and adding to 40 existing holdings. Its largest new stake was Mastercard: 985,920 shares worth $351M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 38% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was New York Times, an estimated $209M trimmed.

  • Farallon Capital Management's largest Q1 2021 buy was Mastercard: 985,920 shares worth $351M.
  • Farallon Capital Management added most to Alexion Pharmaceuticals in Q1 2021, an estimated $546M increase.
  • Farallon Capital Management's biggest Q1 2021 reduction was New York Times, cutting an estimated $209M.
  • Farallon Capital Management fully exited Tiffany & Co. in Q1 2021, selling an estimated $301M.
  • Farallon Capital Management's ten largest holdings make up 33% of its $20.1B portfolio in Q1 2021.
  • Farallon Capital Management opened 120 new positions and closed 20 in Q1 2021.
  • Farallon Capital Management's portfolio value rose 21% quarter-over-quarter to $20.1B.

Based on Farallon Capital Management's 13F filing for Q1 2021, filed 17 May 2021.